DESTINY-Breast09, new breakthroughs in first-line therapy for HER2-positive advanced breast cancer.

ABSTRACT:

SUBMITTER: Li J 

PROVIDER: S-EPMC12314678 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature